iCliniq Logo
HomeHealth articlesMedical oncologyprostate cancer
Cancer

Precancerous Lesions of the Prostate - Causes, Symptoms, and Treatment

Verified data
0

3 min read

Share

Outline

Precancerous prostate lesions, especially PIN, help identify men at a higher risk of prostate cancer. Obtain expert advice and treatment options today.

Written byDr. Bobbili Naga Pavani

Medically reviewed byDr. Rajesh Gulati

Published At November 9, 2022
Reviewed AtJune 5, 2026

What Are Precancerous Lesions of the Prostate?

Precancerous prostate lesions are abnormal cell changes in the prostate gland. These cells do not invade nearby tissues as cancer cells do. However, they appear different from normal cells under a microscope. The most common and well-studied precancerous lesion of the prostate is prostatic intraepithelial neoplasia (PIN). PIN occurs when prostate gland cells begin to grow in an unusual manner. The cells remain within the gland lining and do not spread.

PIN itself does not cause pain or urinary problems. Although it is not prostate cancer, doctors consider it an important warning sign. Some cases of PIN, especially high-grade PIN, may develop into prostate cancer over time.

Precancerous Lesions of the Prostate: Causes, Genetic and Cellular Changes

Loss of control of normal cell growth gives rise to precancerous lesions. Genetic mutations may lead to the rapid appearance of cells or to their inability to repair damaged cells. Changes in hormones, particularly male hormones such as testosterone, may also affect the behavior of prostate cells. Over time, repeated cell damage over a long period probably results in abnormal growth.

Chronic Prostatic Inflammation

Chronic prostatic inflammation, also referred to as persistent infection, entails long-standing irritation and/or swelling of the body’s tissues. Within the prostate, prostatic inflammation can result in injury to normal cells in the long run. When normal cells are adversely affected, they can begin to grow inappropriately. Such unusual cell growth results in prostatic intraepithelial neoplasia (PIN). Prostatic inflammation may result from recurrent infections, urinary issues, or prolonged irritation. In addition, lifestyle factors may contribute to prostatic inflammation. Consumption of high amounts of processed foods, red meat, and unhealthy fats; smoking; and obesity are the leading lifestyle factors responsible for exacerbating inflammation within the body.

Environmental factors may also play a role. Exposure to toxins, chemicals, or pollution may damage prostate health. Aging also increases the risk of prostate cancer, as the prostate naturally changes over a lifetime. Inflammation and the environment may not directly cause cancer, but they may lead to a higher possibility of abnormal cell alterations, such as PIN.

Diagnosis of Precancerous Prostate Lesions

Precancerous prostate lesions are usually diagnosed during prostate cancer tests. These include:

  • Digital rectal examination (DRE) is another test. During this examination, the doctor checks the prostate for abnormal areas.

  • The most important test is prostate biopsy. During a biopsy, small samples of prostate tissue are collected and examined under a microscope. This test can determine whether the cells are normal, precancerous, or cancerous.

Difference Between Precancerous Prostate Lesions and Prostate Cancer

Prostatic lesions that are precancerous do not indicate cancer. These are abnormal cells that do not invade adjacent tissues. If the lesion is cancerous, cancer cells will be present. PIN, especially high-grade PIN, indicates a higher risk of cancer development in the future. However, many men with PIN do not develop prostate cancer. Cancer requires further changes in cells, which may or may not occur.

Can Precancerous Prostate Lesions Transform into Cancer?

Yes, some precancerous lesions can develop into cancer over time. This risk is higher in patients with high-grade PIN. However, the progression is usually slow. This may take many years, and sometimes it does not happen at all. Owing to its slow progression, doctors often choose careful monitoring rather than immediate treatment.

Treatment Strategies for Precancerous Prostate Lesions

Most precancerous prostate lesions do not require immediate treatment. The standard approach is active surveillance. This necessitates regular monitoring with PSA tests, physical examinations, and sometimes repeat biopsies. Active surveillance helps avoid unnecessary treatments and side effects. Treatment is initiated only if there are signs of cancer development. Lifestyle changes are also important. Eating a healthy diet, exercising regularly, maintaining a healthy weight, and quitting smoking may help reduce inflammation and support the prostate health.

In some cases, medications may be used to manage prostate enlargement or reduce the risk. Surgery or radiation is not used for precancerous lesions unless cancer develops.

Conclusion

Precancerous prostate lesions are early abnormal changes in prostate cells that may increase the risk of prostate cancer. Although they are not cancerous, proper monitoring and healthy lifestyle habits are important for supporting prostate health and detecting any harmful changes early. You must speak with your urologist about any concerns.

Key Takeaways

  • Precancerous prostate lesions are abnormal cell changes that are not cancerous.

  • High-grade PIN is the most common precancerous prostate lesion.

  • Most cases are detected during PSA testing or prostate biopsy.

  • Chronic inflammation, aging, and lifestyle factors may increase the risk of developing this disease.

  • Regular monitoring helps detect the early signs of cancer if they develop.

prostate cancer

prostate cancer

A 2-minute survey today may help someone’s father live longer tomorrow.
View insights
Listen to related tracks in our music library

Frequently Asked Questions

A nodule, enlargement, or lesion on the prostate gland is generally not a sign of cancer. There are two prostate lesions: benign prostatic hyperplasia (a condition where there is a non-cancerous enlargement of the prostate gland) and prostatic carcinoma (cancer of the prostate gland). 
Around 40 % to 75 % of focal prostatic lesions visible at magnetic resonance imaging are benign, and the rest are cancerous. It is important to evaluate the risk for malignancy in all prostate lesions.
The growth may go away with or without treatment if it is benign. On the other hand, it also may progress to cancer if not promptly treated. Precancerous cells do not mean the person has cancer, but they increase cancer risk.
The growth of prostate lesions is relatively slow, meaning thereby that it can take years to become large enough to get detected and even larger to metastasize or spread outside the prostate gland. However, some cancers are aggressive and require more urgent treatment.
Around 40 % to 75 % of focal lesions are benign, as seen in MRI (magnetic resonance imaging). A frequency of less than ten percent has been found to be cancerous in several studies.  
The MRI (magnetic resonance imaging) scan of the prostate may identify an area that may or may not contain cancer. This area is called the "indeterminate" lesion. All MRI findings are not cancerous or benign.
A benign lesion of the prostate, like benign prostatic hyperplasia, is a noncancerous prostate gland enlargement and is the most common benign tumor found in men. It often occurs more often in the Western than in Eastern countries.
Any area of damaged tissues is known as a lesion. All tumor growths are lesions, but not all lesions are tumors.
In general, prostate cancers are slow-growing, which means that it takes years to become significant to get detected and even larger to metastasize outside the prostate gland. However, some cases of prostate tumors are fast-growing and need more urgent treatment.
Benign prostatic hyperplasia, or BPH, is a benign type of prostate enlargement that is caused by an increase in the number of normal prostate cells. This condition is more common in older people and is not linked to cancer.
A lesion can be either cancerous or noncancerous. It does not necessarily mean cancerous. Some of the lesions are benign, while others can be cancerous. The benign lesions usually do not need treatment, whereas the cancerous lesions need effective treatment to save one's life.
Prostate cancer can be detected early by testing for the blood's prostate-specific antigen (PSA) levels. Another way to detect prostate cancer is the digital rectal exam (DRE). 
PSA or prostate-specific antigen is a protein produced in the prostate by cancerous and noncancerous cells. Increased PSA levels can indicate the presence of cancer but can also result from noncancerous conditions like benign prostatic hyperplasia (BPH) or an infection.
Source Article IclonSourcesSource Article Arrow
Dr. Rajesh Gulati from iCliniq
Dr. Rajesh Gulati

Family Physician

Consult this doctor

Rate this article

Tags:

precancerous lesionprostate cancer

Related topics

I have white patches on the tongue. What medicines should I take?

Is prostate cancer hereditary?

Will surgery for BPH prevent prostate cancer?

Will chemotherapy work for prostate cancer in an elderly patient?

How to treat the whitish mark on the inner cheek?

Oral Erythroplakia-Clinical Features, Risk Factors, Diagnosis, Differential Diagnosis, and Management

Ask your health query to a doctor online

Medical oncology

*guaranteed answer within 4 hours

Trustpilot

Disclaimer: No content published on this website is intended to be a substitute for professional medical diagnosis, advice or treatment by a trained physician. Seek advice from your physician or other qualified healthcare providers with questions you may have regarding your symptoms and medical condition for a complete medical diagnosis. Do not delay or disregard seeking professional medical advice because of something you have read on this website. Read our Editorial Process to know how we create content for health articles and queries.